Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
Eric W Pefura Yone,1,2 André P Kengne31Department of Internal Medicine and Subspecialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Cameroon; 2Approved Centre for HIV Treatment and Pneumology Service, Yaounde Jamot Hospital, Cameroon; 3South African Medica...
Guardado en:
Autores principales: | Pefura Yone EW, Kengne AP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d56463ec8eef4830bee8755d36b9fe78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
por: Ena J, et al.
Publicado: (2012) -
Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi A, et al.
Publicado: (2013) -
Effect of once-daily FDC treatment era on initiation of cART
por: David M Mosen, et al.
Publicado: (2010) -
New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
por: Patel N, et al.
Publicado: (2012) -
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro J, et al.
Publicado: (2016)